ACROMEGALY
Clinical trials for ACROMEGALY explained in plain language.
Never miss a new study
Get alerted when new ACROMEGALY trials appear
Sign up with your email to follow new studies for ACROMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame unruly growth hormone in acromegaly
Disease control Recruiting nowThis study is testing a new injectable drug, ALXN2420, to see if it works better than a placebo when added to standard acromegaly medications. It will involve about 60 adults whose current treatment isn't fully controlling their hormone levels. The main goal is to see if the new …
Matched conditions: ACROMEGALY
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can a newer drug outperform an older one in preventing spine fractures for acromegaly?
Disease control Recruiting nowThis study aims to see if a drug called Pasireotide LAR is better than another drug, Pegvisomant, at preventing spine fractures in adults with acromegaly whose disease is not well-controlled. Acromegaly often weakens bones, making fractures common. Researchers will compare the ra…
Matched conditions: ACROMEGALY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 3-Month shot tested for rare hormone disorder
Disease control Recruiting nowThis study is testing a new, long-acting injection called Debio 4126 for people with acromegaly, a rare hormonal disorder. The goal is to see if one shot every 12 weeks can keep a key hormone (IGF-1) at a safe level, compared to a placebo. It will also check the safety and side e…
Matched conditions: ACROMEGALY
Phase: PHASE3 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Mar 02, 2026 15:29 UTC
-
First human test of new acromegaly drug begins
Knowledge-focused Recruiting nowThis is the first study testing a new drug called MAR002 in humans. Researchers will give the drug to 45 healthy men to check if it's safe and see how the body processes it. The goal is to gather early information before testing in people with acromegaly, a hormonal disorder.
Matched conditions: ACROMEGALY
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC